| Literature DB >> 36187091 |
Jie Ye1, Weijie Liu1, Xiaozhou Hu1, Hongxiao Jiang1, Mingna Xu1, Haochen Jin1, Mengting Wang1, Zihui Liu1, Qi Chen1, Wencan Wu1, Yunhai Tu1.
Abstract
Purpose: To quantify the retinal vessel density in thyroid-associated ophthalmology (TAO) patients with visual field (VF) defect and examine its associations with mechanical and system vascular risk factors for underlying pathogenesis of VF defect in TAO.Entities:
Keywords: optical coherence tomography angiography (OCTA); pulse pressure (PP); retinal capillary; thyroid-associated ophthalmology (TAO); visual field (VF)
Mesh:
Year: 2022 PMID: 36187091 PMCID: PMC9523314 DOI: 10.3389/fendo.2022.941051
Source DB: PubMed Journal: Front Endocrinol (Lausanne) ISSN: 1664-2392 Impact factor: 6.055
Figure 1The representative OCTA images of TAO patients with or without VF defect. (A, B) In one VF defect TAO patient, his whole SRCP density was 45.3% and whole RPC density was 54.9%. (C, D) In one no-VF defect TAO patient, her whole SRCP density was 45.1% and whole RPC density was 57.9%. SRCP, superficial retinal capillary plexus; RPC, radial peripapillary capillary.
Basic information of all TAO patients.
| VF defect | None VF defect | P | |
|---|---|---|---|
| N | 39 | 23 | – |
| Age, year | 55 ± 8 | 54 ± 7 | 0.648 |
| Gender, M: F | 24:15 | 9:14 | 0.149 |
| SE, diopter | -0.04 ± 1.63 | -0.76 ± 1.70 | 0.109 |
| BCVA, LogMAR | 0.23 ± 0.24 | 0.09 ± 0.14 | 0.007 |
| MD, dB | -7.39 ± 6.36 | -0.54 ± 0.79 | < 0.001 |
| Horizontal MI | 0.55 ± 0.11 | 0.46 ± 0.12 | 0.006 |
| Vertical MI | 0.64 ± 0.12 | 0.51 ± 0.11 | < 0.001 |
M, male; F, female; SE, spherical equivalent; BCVA, best-corrected visual acuity; MD, mean deviation; MI, muscle index; VF, visual field.
Blood pressure and IOP information in all TAO patients.
| VF defect | None VF defect | P | |
|---|---|---|---|
| PP, mmHg | |||
| Mean | 52.06 ± 12.27 | 46.87 ± 5.40 | 0.026 |
| Fluctuation | 6.49 ± 2.91 | 6.71 ± 1.56 | 0.733 |
| IOP, mmHg | |||
| Mean | 18.44 ± 5.00 | 15.99 ± 4.85 | 0.065 |
| Fluctuation | 2.72 ± 1.55 | 2.57 ± 1.53 | 0.700 |
PP, pulse pressure; IOP, intraocular pressure; VF, visual field.
Figure 2Diurnal rhythm of pulse pressure and IOP in TAO patients with and without VF defect. (A) Diurnal rhythm of PP in TAO patients with and without VF defect, * indicated significant difference between two groups. (B) Diurnal rhythm of PP in TAO patients with VF defect, dashed line indicates the mean PP value (52.06 mmHg) and * indicates the significant difference between PP value at that measurement point and mean value. (C) Diurnal rhythm of PP in TAO patients without VF defect, dashed line indicates the mean PP value (46.87 mmHg) and * indicates the significant difference between PP value at that measurement point and mean value. (D) Diurnal rhythm of IOP in TAO patients with and without VF defect, * indicates significant difference between two groups. (E) Diurnal rhythm of IOP in TAO patients with VF defect, dashed line indicates the mean IOP value (18.44 mmHg) and * indicates the significant difference between IOP value at that measurement point and mean value. (F) Diurnal rhythm of IOP in TAO patients without VF defect; dashed line indicates the mean PP value (15.99 mmHg) and * indicates the significant difference between PP value at that measurement point and mean value. PP, pulse pressure; IOP, intraocular pressure; VF, visual field.
Alteration of retinal capillary density and peripapillary RNFL thickness.
| VF defect | None VF defect | P | |
|---|---|---|---|
| RPC density, % | |||
| Whole | 51.86 ± 3.43 | 53.51 ± 2.58 | 0.025 (0.021) |
| Superior | 51.53 ± 4.14 | 53.71 ± 2.86 | 0.015 (0.008) |
| Inferior | 52.19 ± 3.12 | 53.31 ± 2.69 | 0.078 (0.052) |
| SRCP density, % | |||
| Whole | 41.09 ± 4.72 | 41.73 ± 5.63 | 0.314 (0.459) |
| Superior | 45.59 ± 6.52 | 47.39 ± 6.16 | 0.143 (0.225) |
| Nasal | 44.05 ± 4.67 | 44.30 ± 6.92 | 0.432 (0.436) |
| Inferior | 45.56 ± 5.06 | 46.52 ± 6.24 | 0.256 (0.450) |
| Temporal | 43.39 ± 5.90 | 43.09 ± 8.54 | 0.436 (0.318) |
| pRNFL thickness, μm | |||
| Whole | 113.79 ± 14.32 | 118.26± 7.50 | 0.056 (0.055) |
| Superior | 114.36 ± 16.35 | 118.39 ± 9.70 | 0.113 (0.057) |
| Inferior | 113.44 ± 15.02 | 118.00 ± 7.71 | 0.060 (0.051) |
M, male; F, female; SE, spherical equivalent; BCVA, best-corrected visual acuity; MD, mean deviation; MI, muscle index; VF, visual field. P values in parentheses were the P values after the adjustment for the IOP by GEE analysis.
The GEE analysis with RPC as the predictor factor.
| Parameters | Univariable | Multivariable | ||||
|---|---|---|---|---|---|---|
| β | Standard error | P | β | Standard error | P | |
| Age, year | -0.075 | 0.055 | 0.172 | – | – | – |
| Gender, Male | 1.225 | 0.817 | 0.134 | – | – | – |
| SE, diopter | -0.044 | 0.249 | 0.860 | – | – | – |
| Horizontal MI | -6.096 | 3.333 | 0.067 | – | – | – |
| Vertical MI | -3.377 | 3.050 | 0.268 | – | – | – |
| PP mean | -0.094 | 0.038 | 0.013 | -0.082 | 0.038 | 0.029 |
| PP Fluctuation | -0.343 | 0.163 | 0.035 | -0.279 | 0.159 | 0.080 |
| IOP mean | -0.063 | 0.083 | 0.449 | – | – | – |
| IOP Fluctuation | 0.197 | 0.271 | 0.467 | – | – | – |
SE, spherical equivalent; MI, muscle index; PP, pulse pressure; IOP, intraocular pressure; GEE, general estimating equation.
Summary of previous studies on retinal perfusion changes in TAO.
| Study | Groups | Retinal perfusion changes |
|---|---|---|
| Current study | TAO (1) with and (2) without VF defect | The reduced RPC density in TAO patients with VF defect compared to patients without VF defect. |
| Zhang et al. | TAO (1) with and (2) without DON | The reduced RPC density and unchanged SRCP density in TAO patients with DON compared to patients without DON. |
| Wu et al. | (1) TAO with DON; | The reduced SRCP density in TAO patients with DON compared to normal controls. |
| Wu et al. | (1) TAO; (2) normal controls. | The reduced SRCP density in TAO patients compared to normal controls. |
| Yang et al. | (1) Severe inactive TAO; (2) normal controls. | The retinal venous diameter decreased significantly in severe TAO. |
| Tehrani et al. | (1) Active TAO; (2) not active not compressive TAO; (3) normal controls. | The reduced RPC density and SRCP density in active TAO patients compared to not active not compressive TAO patients and normal controls. |
| Wu et al. | TAO (1) with and (2) without DON | The reduced RPC density in TAO patients with DON compared to patients without DON. |
TAO, thyroid-associated ophthalmology; RPC, radial peripapillary capillary; VF, visual field; SRCP, superficial retinal capillary plexus; DON, dysthyroid optic neuropathy.